Nicolas Violle

Nicolas Violle is the CEO of SYNCROSOME, a preclinical efficacy CRO, since October 2023, and has served as CEO of ETAP-Lab, an independent CRO specializing in efficacy and toxicology studies in rodents, since January 2009. With a background in neuroscience, Nicolas obtained a PhD from Université Henri Poincaré, Nancy 1, and has extensive teaching experience in biostatistics and neuroscience at various universities. Additionally, Nicolas holds multiple degrees related to management, project management, and animal experimentation, contributing to expertise in the field of preclinical research and studies that enhance bench-to-bedside translation.